Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEAMERICAN:IGC BATS:JEMA NYSEARCA:ROOF NYSEARCA:VSL On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeIGCIGC Pharma$0.27-0.6%$0.30$0.24▼$0.50$26.68M0.46590,920 shs698,491 shsJEMAJPMorgan ActiveBuilders Emerging Markets Equity ETF$62.59-5.5%$61.05$42.42▼$66.68$1.76B0.66120,953 shs183,803 shsROOFNYLI CBRE NextGen Real Estate ETF$0.19$17.87$20.00▼$22.69$1.41M0.9569,150 shs3,000 shsVSLVolshares Large Cap ETF$35.47-0.1%$35.47$34.13▼$44.65$3.55MN/A1,735 shs1,400 shs The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceIGCIGC Pharma-3.02%-4.92%-7.43%+5.38%-12.59%JEMAJPMorgan ActiveBuilders Emerging Markets Equity ETF+0.50%+2.51%+9.04%+27.53%+59.37%ROOFNYLI CBRE NextGen Real Estate ETF0.00%0.00%-99.08%-99.08%-99.08%VSLVolshares Large Cap ETF0.00%0.00%0.00%0.00%0.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeIGCIGC Pharma$0.27-0.6%$0.30$0.24▼$0.50$26.68M0.46590,920 shs698,491 shsJEMAJPMorgan ActiveBuilders Emerging Markets Equity ETF$62.59-5.5%$61.05$42.42▼$66.68$1.76B0.66120,953 shs183,803 shsROOFNYLI CBRE NextGen Real Estate ETF$0.19$17.87$20.00▼$22.69$1.41M0.9569,150 shs3,000 shsVSLVolshares Large Cap ETF$35.47-0.1%$35.47$34.13▼$44.65$3.55MN/A1,735 shs1,400 shs The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceIGCIGC Pharma-3.02%-4.92%-7.43%+5.38%-12.59%JEMAJPMorgan ActiveBuilders Emerging Markets Equity ETF+0.50%+2.51%+9.04%+27.53%+59.37%ROOFNYLI CBRE NextGen Real Estate ETF0.00%0.00%-99.08%-99.08%-99.08%VSLVolshares Large Cap ETF0.00%0.00%0.00%0.00%0.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceIGCIGC Pharma 2.50Moderate Buy$5.501,975.47% UpsideJEMAJPMorgan ActiveBuilders Emerging Markets Equity ETF 2.71Moderate Buy$62.59N/AROOFNYLI CBRE NextGen Real Estate ETF 2.52Moderate Buy$0.19N/AVSLVolshares Large Cap ETF 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest VSL, ROOF, JEMA, and IGC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/8/2026IGCIGC Pharma Ascendiant Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$5.25 ➝ $5.504/8/2026IGCIGC Pharma Ascendiant Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$5.00 ➝ $5.25(Data available from 6/23/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookIGCIGC Pharma$1.27M20.88N/AN/A$0.08 per share3.31JEMAJPMorgan ActiveBuilders Emerging Markets Equity ETFN/AN/AN/AN/AN/AN/AROOFNYLI CBRE NextGen Real Estate ETFN/AN/AN/AN/AN/AN/AVSLVolshares Large Cap ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateIGCIGC PharmaN/A-$0.07N/AN/AN/A-583.91%-80.89%-63.75%N/AJEMAJPMorgan ActiveBuilders Emerging Markets Equity ETFN/AN/A15.19N/AN/AN/AN/AN/AN/AROOFNYLI CBRE NextGen Real Estate ETFN/AN/A26.87N/AN/AN/AN/AN/AN/AVSLVolshares Large Cap ETFN/AN/AN/AN/AN/AN/AN/AN/AN/ALatest VSL, ROOF, JEMA, and IGC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2026Q1 2026IGCIGC PharmaN/A-$0.02N/A-$0.02N/A$0.32 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthIGCIGC PharmaN/AN/AN/AN/AN/AJEMAJPMorgan ActiveBuilders Emerging Markets Equity ETF$0.911.45%N/AN/AN/AROOFNYLI CBRE NextGen Real Estate ETF$0.57300.00%N/AN/AN/AVSLVolshares Large Cap ETFN/A0.00%N/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioIGCIGC Pharma0.020.830.53JEMAJPMorgan ActiveBuilders Emerging Markets Equity ETFN/AN/AN/AROOFNYLI CBRE NextGen Real Estate ETFN/AN/AN/AVSLVolshares Large Cap ETFN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipIGCIGC Pharma3.87%JEMAJPMorgan ActiveBuilders Emerging Markets Equity ETFN/AROOFNYLI CBRE NextGen Real Estate ETFN/AVSLVolshares Large Cap ETFN/AInsider OwnershipCompanyInsider OwnershipIGCIGC Pharma23.66%JEMAJPMorgan ActiveBuilders Emerging Markets Equity ETFN/AROOFNYLI CBRE NextGen Real Estate ETFN/AVSLVolshares Large Cap ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableIGCIGC Pharma61100.09 million76.41 millionN/AJEMAJPMorgan ActiveBuilders Emerging Markets Equity ETFN/A28.10 millionN/ANot OptionableROOFNYLI CBRE NextGen Real Estate ETFN/A7.40 millionN/ANot OptionableVSLVolshares Large Cap ETFN/A100,000N/ANot OptionableVSL, ROOF, JEMA, and IGC HeadlinesRecent News About These CompaniesNo headlines for this company have been tracked by MarketBeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSpaceX Gets the Attention, But These 4 Stocks Could Get the ReturnsBy Bridget Bennett | May 25, 20265 Stocks Winning the AI Race While Everyone Watches NVIDIABy Bridget Bennett | May 26, 20265 Under-the-Radar AI Stocks to Watch in JuneBy Thomas Hughes | May 31, 2026MongoDB Is the Latest SaaS Apocalypse Victim to Say "Not Today"By Sam Quirke | June 3, 2026Why BitMine’s Selloff May Be Missing the Bigger StoryBy Jeffrey Neal Johnson | June 18, 2026VSL, ROOF, JEMA, and IGC Company DescriptionsIGC Pharma NYSEAMERICAN:IGC$0.26 0.00 (-0.60%) Closing price 05:16 PM EasternExtended Trading$0.27 +0.01 (+3.40%) As of 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.IGC Pharma, Inc., a clinical stage pharmaceutical company, engages in developing treatments for Alzheimer's disease. The company's lead product is IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer's; and TGR-63, IGC-1C, IGC-M3, and LMP in pre-clinical development. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. The company was incorporated in 2005 and is headquartered in Potomac, Maryland.JPMorgan ActiveBuilders Emerging Markets Equity ETF BATS:JEMA$62.59 -3.66 (-5.52%) As of 04:15 PM EasternThe JPMorgan ActiveBuilders Emerging Markets Equity ETF (JEMA) is an exchange-traded fund that is based on the MSCI Emerging Markets index. The fund is an actively-managed fund utilizing emerging market equity strategies across countries, regions, styles, and market capitalizations. JEMA was launched on Mar 10, 2021 and is managed by JPMorgan Chase.NYLI CBRE NextGen Real Estate ETF NYSEARCA:ROOF$0.19 0.00 (0.00%) As of 06/10/2026The IQ U.S. Real Estate Small Cap ETF (ROOF) is an exchange-traded fund that is based on the IQ CBRE NextGen Real Estate index. The fund tracks a tier-weighted index of developed market companies classified under real estate sectors that are expected to benefit from trends affecting property sectors in the global economy. ROOF was launched on Jun 14, 2011 and is managed by IndexIQ.Volshares Large Cap ETF NYSEARCA:VSL$35.47 -0.04 (-0.11%) As of 07/28/2022 More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Oracle’s Sell-Off Looks More Like a Mispricing Than a Warning These AI Stocks Have Insider Selling, But Buyers Still Have a Reason to Stay Apple’s Intel Deal Arrives at the Right Time for Its Stock Micron’s Sudden Plunge May Be an AI Buying Chance Amazon’s Pullback Deepens as a New FTC Risk Hits the Stock The Biotech Sector Looks Ready for a Multi-Year Breakout—Here's What to Watch. How Does D-Wave's New Simulator Change the Quantum Computing Landscape? How Intel Is Packaging the Future of American Chips Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
